New Era Begins In Korea: Policy Predictions For Biopharma

Doctors’ Dispute, R&D Investment, AI Technology In Focus

 
• By Jung Won Shin
  
Korean flag and medicines
Biopharma Policy Direction In Spotlight After South Korean Election (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Elections

More from South Korea